Richter-Helm has more than 25 years of experience in the development and GMP-compliant production of recombinant proteins, plasmid DNA and microbial vaccines. With more than 140 employees operating from three sites Richter-Helm is offering customized state of the art solutions for all steps in biopharmaceutical projects via contract development and manufacturing services in GMP facilities for microbial production.
Besides a strong expertise in E. coli Richter-Helm successfully produces proteins in yeast (e.g. Pichia pastoris technology). Thus Richter-Helm is the ideal partner for biopharmaceuticals development by offering material from pre-clinical and clinical trials to market supply at a large scale.
In addition Richter-Helm is the platform of Gedeon-Richter and Helm AG for worldwide licensing options as well as partnerships for co-development and marketing of biopharmaceutical development projects.
Richter-Helm BioTec GmbH & Co. KG
Dr. Kai Pohlmeyer
Head of Business Development